Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target

Figure 4

Overall survival of 13 cancer types including ACC, BLCA, BRCA, KICH, KIRC, LGG, OV, PCPG, SKCM, STAD, TGCT, THCA, and THYM according to tumor mutation burden (TMB).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)